Focus 2: A Randomized, Double-blinded, Multicentre, Phase Iii Trial Of The Efficacy And Safety Of Ceftaroline Fosamil Versus Ceftriaxone In Community-acquired Pneumonia

Title

Focus 2: A Randomized, Double-blinded, Multicentre, Phase Iii Trial Of The Efficacy And Safety Of Ceftaroline Fosamil Versus Ceftriaxone In Community-acquired Pneumonia

Creator

Low D E; File T M; Eckburg P B; Talbot G H; Friedland H D; Lee J; Llorens L; Critchley I A; Thye D A; Investigators Focus

Publisher

Journal of Antimicrobial Chemotherapy

Date

2011
2011-04

Subject

2-phase 3; adults; antimicrobial therapy; CABP; CAP; collection; guidelines; Infectious Diseases; integrated analysis; management; Microbiology; penicillin-binding proteins; Pharmacology & Pharmacy; staphylococcus-aureus; streptococcus-pneumoniae; streptococcus-pneumoniae; therapy

Identifier

Format

Journal Article or Conference Abstract Publication

Search for Full-text

Users with a NEOMED Library login can search for full-text journal articles at the following url: https://libraryguides.neomed.edu/home

Rights

Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).

Pages

III33-III44

Volume

66

Citation

Low D E; File T M; Eckburg P B; Talbot G H; Friedland H D; Lee J; Llorens L; Critchley I A; Thye D A; Investigators Focus, “Focus 2: A Randomized, Double-blinded, Multicentre, Phase Iii Trial Of The Efficacy And Safety Of Ceftaroline Fosamil Versus Ceftriaxone In Community-acquired Pneumonia,” NEOMED Bibliography Database, accessed January 28, 2021, https://neomed.omeka.net/items/show/9845.

Social Bookmarking